A practical approach to reporting treatment abandonment in pediatric chronic conditions

Meaghann S. Weaver, Ramandeep S. Arora, Scott Howard, Carmen E. Salaverria, Yen Lin Liu, Raul C. Ribeiro, Catherine G. Lam

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Treatment abandonment, the failure to complete therapy that is required for definitive disease control, frequently causes treatment failure for pediatric patients in low- and middle-income countries with chronic conditions, particularly cancer. Other forms of incomplete treatment affecting children in all settings, such as nonadherence and loss to follow-up, are often confused with treatment abandonment. Unclear definitions of incomplete treatment dramatically affect reported outcomes. To facilitate disease-specific and cross-sector analyses, we outline a practical approach to categorize forms of incomplete treatment, present distinct semantic categories with case examples and provide an algorithm that could be tailored to disease- and context-specific needs. Pediatr Blood Cancer 2015;62:565-570.

Original languageEnglish (US)
Pages (from-to)565-570
Number of pages6
JournalPediatric Blood and Cancer
Volume62
Issue number4
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Pediatrics
Treatment Failure
Therapeutics
Semantics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Weaver, M. S., Arora, R. S., Howard, S., Salaverria, C. E., Liu, Y. L., Ribeiro, R. C., & Lam, C. G. (2015). A practical approach to reporting treatment abandonment in pediatric chronic conditions. Pediatric Blood and Cancer, 62(4), 565-570. https://doi.org/10.1002/pbc.25403

A practical approach to reporting treatment abandonment in pediatric chronic conditions. / Weaver, Meaghann S.; Arora, Ramandeep S.; Howard, Scott; Salaverria, Carmen E.; Liu, Yen Lin; Ribeiro, Raul C.; Lam, Catherine G.

In: Pediatric Blood and Cancer, Vol. 62, No. 4, 01.01.2015, p. 565-570.

Research output: Contribution to journalReview article

Weaver, MS, Arora, RS, Howard, S, Salaverria, CE, Liu, YL, Ribeiro, RC & Lam, CG 2015, 'A practical approach to reporting treatment abandonment in pediatric chronic conditions', Pediatric Blood and Cancer, vol. 62, no. 4, pp. 565-570. https://doi.org/10.1002/pbc.25403
Weaver, Meaghann S. ; Arora, Ramandeep S. ; Howard, Scott ; Salaverria, Carmen E. ; Liu, Yen Lin ; Ribeiro, Raul C. ; Lam, Catherine G. / A practical approach to reporting treatment abandonment in pediatric chronic conditions. In: Pediatric Blood and Cancer. 2015 ; Vol. 62, No. 4. pp. 565-570.
@article{a922bf1508704c74bd352c8da4574f03,
title = "A practical approach to reporting treatment abandonment in pediatric chronic conditions",
abstract = "Treatment abandonment, the failure to complete therapy that is required for definitive disease control, frequently causes treatment failure for pediatric patients in low- and middle-income countries with chronic conditions, particularly cancer. Other forms of incomplete treatment affecting children in all settings, such as nonadherence and loss to follow-up, are often confused with treatment abandonment. Unclear definitions of incomplete treatment dramatically affect reported outcomes. To facilitate disease-specific and cross-sector analyses, we outline a practical approach to categorize forms of incomplete treatment, present distinct semantic categories with case examples and provide an algorithm that could be tailored to disease- and context-specific needs. Pediatr Blood Cancer 2015;62:565-570.",
author = "Weaver, {Meaghann S.} and Arora, {Ramandeep S.} and Scott Howard and Salaverria, {Carmen E.} and Liu, {Yen Lin} and Ribeiro, {Raul C.} and Lam, {Catherine G.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/pbc.25403",
language = "English (US)",
volume = "62",
pages = "565--570",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - A practical approach to reporting treatment abandonment in pediatric chronic conditions

AU - Weaver, Meaghann S.

AU - Arora, Ramandeep S.

AU - Howard, Scott

AU - Salaverria, Carmen E.

AU - Liu, Yen Lin

AU - Ribeiro, Raul C.

AU - Lam, Catherine G.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Treatment abandonment, the failure to complete therapy that is required for definitive disease control, frequently causes treatment failure for pediatric patients in low- and middle-income countries with chronic conditions, particularly cancer. Other forms of incomplete treatment affecting children in all settings, such as nonadherence and loss to follow-up, are often confused with treatment abandonment. Unclear definitions of incomplete treatment dramatically affect reported outcomes. To facilitate disease-specific and cross-sector analyses, we outline a practical approach to categorize forms of incomplete treatment, present distinct semantic categories with case examples and provide an algorithm that could be tailored to disease- and context-specific needs. Pediatr Blood Cancer 2015;62:565-570.

AB - Treatment abandonment, the failure to complete therapy that is required for definitive disease control, frequently causes treatment failure for pediatric patients in low- and middle-income countries with chronic conditions, particularly cancer. Other forms of incomplete treatment affecting children in all settings, such as nonadherence and loss to follow-up, are often confused with treatment abandonment. Unclear definitions of incomplete treatment dramatically affect reported outcomes. To facilitate disease-specific and cross-sector analyses, we outline a practical approach to categorize forms of incomplete treatment, present distinct semantic categories with case examples and provide an algorithm that could be tailored to disease- and context-specific needs. Pediatr Blood Cancer 2015;62:565-570.

UR - http://www.scopus.com/inward/record.url?scp=84923248148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923248148&partnerID=8YFLogxK

U2 - 10.1002/pbc.25403

DO - 10.1002/pbc.25403

M3 - Review article

VL - 62

SP - 565

EP - 570

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 4

ER -